Endomag Clinical References

Clinical references:

1. Douek M, Klass J, Monypenny I, et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol. 2014;21:1237–45.

2. Thill M, et al. The Central-European SentiMag study: sentinel lymph node biopsy with super paramagnetic iron oxide (SPIO) vs. radioisotope. Breast 2014;23:175–9.

3. Rubio IT, et al. The super paramagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. 2015;41:46–51.

4. Pinero-Madrona A, et al. Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: a comparative non-inferiority study. Eur J Surg Oncol. 2015;41:991–7.

5. Ghilli M, et al. The supramagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment. Eur J Cancer Care (Engl). 2015. doi:10.1111/ ecc.12385

6. Houpeau JL, et al. Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial. J Surg Oncol. 2016 Jan 12. doi: 10.1002/ jso.24164

7. Teshome M, Wei C, Hunt KK, et al. Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Metaanalysis. Ann Surg Oncol. 2016 Feb 18.